The pituitary cancer market is growing mainly due to rising prevalence of pituitary cancer. According to a recent study report published by the Market Research Future, the pericarditis market is booming and expected to gain prominence over the forecast period.
The pituitary cancer market is expected to reach USD 736.4 million by 2030, with a 7.8% growth rate over the forecast period 2022-2030.
Pituitary tumours are non-cancerous tumours present in the pituitary gland that don't spread beyond the skull. Some pituitary tumours, known as secreting tumours, affect hormone levels. These tumours can cause quite unusual symptoms. There are different types of hormone producing tumours such as prolactinomas which can cause infertility, thyroid stimulating hormone producing tumours which can cause an overactive thyroid, and others. Pituitary tumors are basically divided into three group i.e. benign pituitary adenomas, invasive pituitary adenomas, and pituitary carcinomas. Pituitary carcinomas are malignant in nature and can spread into other areas of the central nervous system or outside of the central nervous system. The diagnosis of pituitary tumour can be done by various methods such as physical examination, visual field exam, eye exam, neurological exam, MRI (magnetic resonance imaging), blood chemistry study, blood tests, high-dose dexamethasone suppression test, venous sampling for pituitary tumours, biopsy, and others.
Other push factors such as, rising cases pituitary cancer, and related complications, increasing urbanization and changing lifestyles, improvement in reimbursement policies, developing retail and pharmaceutical industries, preventing occurrence of disease, and rapid advancements in product offerings are also fuelling the growth of the market. According to epidemiological data suggested by cancer registries, the prevalence of pituitary adenomas is 25 cases per 100,000 inhabitants.
Despite these drivers, presence of misbranded drugs, side effects associated with surgical interventions, expiration of blockbuster drugs, strict FDA regulations, are expected to hinder the growth of the market during the forecast period.
The market overview of pituitary cancer, focusing on pituitary tumors treatment, showcases a rising demand for specialized therapies. Advancements in diagnostic techniques and personalized medicine drive the market forward. With a growing emphasis on targeted treatments and innovative approaches, the market witnesses increased investment and research activities aimed at improving patient outcomes and quality of life.
Pituitary Cancer Market - Competitive Analysis
The pituitary cancer market is currently dominated by various players. Due to rising cases of pituitary cancer, and related complications various existing and new marketers are continuously coming up with advanced products to control various health conditions. The global pituitary cancer market is currently dominated by numerous players.
The Pituitary Cancer major key players include Amgen Inc., Astellas Pharma Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Celgene Corporation, Merck & Co., Inc., Novartis AG, Pfizer Inc., AstraZeneca, Mylan N.V., Johnson & Johnson Services, Inc., Onxeo, Ipsen Pharmaceuticals, Salix Pharmaceuticals, Inc., and Strides Pharma Science Limited.
Valeant is one of them by holding a strong share in the market. The company is a pharmaceutical company that engages in the development, manufacturing, and marketing of a range of pharmaceutical products. Valeant provides specialty over-the-counter (OTC) pharmaceutical products in the areas of neurology therapeutic classes, and dermatology.
Pituitary Cancer Market - Regional Analysis
The Americas dominate the pituitary cancer market owing to the rising prevalence of pituitary cancer in this region, presence of major market players, and high adoption rate of new technology. On the regional basis, the Americas pituitary cancer market is segmented into two major regions, i.e., North America and South America. The North American region holds the major share of the global pituitary cancer market.
Related Reports –
For more information visit at MarketResearchFuture
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)